Menu

• Ask a Health Expert about SYSTEMIC SCLEROSIS
• Post Your Side Effect related to SYSTEMIC SCLEROSIS
• SYSTEMIC SCLEROSIS and FDA Warnings
• SYSTEMIC SCLEROSIS in Patients Wiki
• Report SYSTEMIC SCLEROSIS in Drug Side Effect Survey

SYSTEMIC SCLEROSIS side effect

What is SYSTEMIC SCLEROSIS ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Cozaar Side Effects Report #5417520-3
Physician from UNITED KINGDOM reported COZAAR problem on Aug 06, 2007. Male patient, 38 years of age, was diagnosed with systemic sclerosis, ischaemia and was treated with COZAAR. After drug was administered, patient experienced the following problems/side effects: systemic sclerosis, . COZAAR dosage: unknown. During the same period patient was treated with ILOPROST, NIFEDIPINE, CLOPIDOGREL BISULPHATE, FLUOXETINE, LANSOPRAZOLE, METHYLPREDNISOLONE, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Megestrol Side Effects Report #5334808-5
MEGESTROL ACETATE problem was reported by a Health Professional from SPAIN on July 17, 2006. Female patient, 51 years of age, was diagnosed with biliary cirrhosis primary, asthma and was treated with MEGESTROL ACETATE. After drug was administered, patient experienced the following problems/side effects: scleroderma, systemic sclerosis, . MEGESTROL ACETATE dosage: unknown. During the same period patient was treated with URSODIOL, BRONCHODILATOR, STEROIDS. Patient recovered.

Januvia Side Effects Report #5586102-5
Physician from UNITED STATES reported JANUVIA problem on Jan 04, 2008. Female patient, 75 years of age, was diagnosed with blood glucose and was treated with JANUVIA. After drug was administered, patient experienced the following problems/side effects: oedema, skin hyperpigmentation, systemic sclerosis, . JANUVIA dosage: unknown. During the same period patient was treated with AMARYL. Patient was hospitalized. Patient recovered.

Fluoxetine Side Effects Report #5442150-7
FLUOXETINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 21, 2007. Male patient, 38 years of age, was diagnosed with systemic sclerosis and was treated with FLUOXETINE. After drug was administered, patient experienced the following problems/side effects: anaemia, gangrene, systemic sclerosis, . FLUOXETINE dosage: unknown. During the same period patient was treated with LOSARTAN POTASSIUM, ILOPROST, NIFEDIPINE, CLOPIDOGREL, LANSOPRAZOLE, BLOOD TRANSFUSION. Patient recovered.


Cozaar Side Effects Report #5451781-X
Physician from UNITED KINGDOM reported COZAAR problem on Sept 10, 2007. Male patient, 38 years of age, weighting 147.7 lb, was diagnosed with systemic sclerosis, ischaemia, hypersensitivity and was treated with COZAAR. After drug was administered, patient experienced the following problems/side effects: rash macular, systemic sclerosis, . COZAAR dosage: unknown. During the same period patient was treated with ILOPROST, NIFEDIPINE, CLOPIDOGREL BISULPHATE, FLUOXETINE, LANSOPRAZOLE, METHYLPREDNISOLONE, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Methylprednisolo Side Effects Report #5439088-8
METHYLPREDNISOLONE problem was reported by a Health Professional from UNITED KINGDOM on Aug 21, 2007. Male patient, 38 years of age, was diagnosed with peripheral ischaemia, systemic sclerosis and was treated with METHYLPREDNISOLONE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, systemic sclerosis, . METHYLPREDNISOLONE dosage: unknown. During the same period patient was treated with LOSARTAN POTASSIUM, ILOPROST, NIFEDIPINE, LANSOPRAZOLE, FLUOXETINE, CLOPIDOGREL BISULPHATE, CYCLOPHOSPHAMIDE. Patient recovered.

Magnevist Side Effects Report #5273019-9
Health Professional from UNITED STATES reported MAGNEVIST problem on Mar 09, 2007. Female patient, 68 years of age, was diagnosed with angiogram, diabetic neuropathy and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: mobility decreased, nephrogenic fibrosing dermopathy, systemic sclerosis, . MAGNEVIST dosage: 40 ML, 1 DOSE. During the same period patient was treated with ULTRAVIST, NEURONTIN. Patient recovered.